Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Neuron
|
January 9, 2015
Cell lineage analysis in human brain using endogenous retroelements
Gilad D Evrony, Eunjung Lee, Bhaven K Mehta, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 3, 2023
Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria
Alessandra Ottonello, Jessica A Wyllie, Oussama Yahiaoui, et al.
Biorxiv : the Preprint Server for Biology
|
June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Nature
|
February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Nature Communications
|
February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
James Logue, Robert M Johnson, Nita Patel, et al.
Chemical Science
|
March 15, 2024
Modular synthesis of functional libraries by accelerated SuFEx click chemistry
Joshua A Homer, Rebecca A Koelln, Andrew S Barrow, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity
Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Science Translational Medicine
|
November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Nature
|
April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Neuron
|
January 9, 2015
Cell lineage analysis in human brain using endogenous retroelements
Gilad D Evrony, Eunjung Lee, Bhaven K Mehta, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 3, 2023
Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria
Alessandra Ottonello, Jessica A Wyllie, Oussama Yahiaoui, et al.
Biorxiv : the Preprint Server for Biology
|
June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infection
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Nature
|
February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2
David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Nature Communications
|
February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
James Logue, Robert M Johnson, Nita Patel, et al.
Chemical Science
|
March 15, 2024
Modular synthesis of functional libraries by accelerated SuFEx click chemistry
Joshua A Homer, Rebecca A Koelln, Andrew S Barrow, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity
Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Science Translational Medicine
|
November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Nature
|
April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Page
of 3